BreezeBio logo

BreezeBio

Genetic Medicine Delivered

64 employees · est. 2016 · Brisbane, United States

VS
GenEdit logo

GenEdit

Delivering the potential of genetic medicines

47 employees · est. 2016 · South San Francisco, United...

BreezeBio is the larger of the two.

Side-by-Side Comparison

BreezeBio GenEdit
Founded
2016 2016
Headquarters
Brisbane, United States South San Francisco, United States
Employees
64 larger 47
Industry
Biotechnology Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage
Series B Series A
Total Funding
$118.50M $67.73M
Funding Rounds
6 7
Services
Targeted delivery of genetic medicines, Development of immune modulation therapies, Research and development of precision genetic medicine platforms Development of Precision Genetic Medicines, Targeted Delivery of Genetic Payloads, Restoration of Immune Balance, Pipeline for Autoimmune and Oncology Therapies
Target Customers
Healthcare professionals, Biopharmaceutical companies, Patients with autoimmune diseases, Research institutions Patients with Autoimmune Diseases, Healthcare Providers, Biotechnology Researchers, Pharmaceutical Companies
Taxonomy
Precision Medicine, Genetic Medicine, Non-Viral Delivery, NanoGalaxy® Platform, Nanoparticles, MRNA Delivery, Immune Cells, Tissue Specific Delivery, Autoimmune Diseases, Oncology, Type 1 Diabetes, Immune Tolerance, Therapeutic Pipeline, IND-Enabling Studies Genetic Medicines, Gene Therapy Delivery, Polymer Nanoparticles, Non-Viral Gene Editing, Therapeutic Candidates, NanoGalaxy Platform, Target Tissue Delivery, Gene Therapy Innovation, Non-Lipid Nanoparticles, Therapeutic Gene Editing, High Unmet Medical Need, Iterative Screening Process, Non-Viral Therapeutics, Genetic Disease Treatment, Safer Gene Editing
Website
breezebio.com genedit.com
BreezeBio logo

About BreezeBio

BreezeBio, with the slogan "Genetic Medicine Delivered," is a biotechnology company focused on creating precision genetic medicines. Established in 2016 and situated in the South San Francisco area, the company specializes in non-viral delivery methods for genetic therapies across biologically relev...

GenEdit logo

About GenEdit

GenEdit, a biotechnology startup founded in 2016 and headquartered in the United States, is pioneering solutions in the realm of genetic medicines with its innovative slogan: "Delivering the potential of genetic medicines". The company addresses a critical bottleneck in the field—effective delivery...

We will tell you when either one moves

BounceWatch watches BreezeBio and GenEdit for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at BreezeBio and GenEdit — by email.

Frequently Asked Questions

BreezeBio — Genetic Medicine Delivered. GenEdit — Delivering the potential of genetic medicines. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
BreezeBio has raised $118.50M while GenEdit has raised $67.73M.
BreezeBio and GenEdit operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare BreezeBio with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at BreezeBio on 9 Jun 2026, and GenEdit on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy